Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2009Journal of Clinical InvestigationOpen Access

Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation

View Full Paper
Ask AI
Bookmark
Share

Authors

HYHung‐Chih YangNational Taiwan UniversitySXSifei XingHoward Hughes Medical InstituteLSLiang ShanWashington University in St. Louis

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yang et al. (2009) studied this question.

synapsesocial.com/papers/6a9be59588fb76f576fb4d74https://doi.org/10.1172/jci39199
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Primary Cell Model for Activation-Inducible Human Immunodeficiency Virus2007 · 32 citations
  2. 2Microbicide Fails to Protect Against HIV2008 · 49 citations
  3. 3High-Titer Human Immunodeficiency Virus Type 1-Based Vector Systems for Gene Delivery into Nondividing Cells1998 · 311 citations
  4. 4Novel Single-Cell-Level Phenotypic Assay for Residual Drug Susceptibility and Reduced Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 12004 · 183 citations
  5. 5Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy2000 · 552 citations